Department of Neurology, University Hospital in Krakow, Krakow, Poland.
Department of Neurology, Jagiellonian University Medical College, Krakow, Poland.
Brain Behav. 2023 Feb;13(2):e2849. doi: 10.1002/brb3.2849. Epub 2023 Jan 9.
Limited evidence exists on sex differences in post-COVID fatigue among non-hospitalized patients. Therefore, aim of the study was to evaluate the course of chronic fatigue symptoms in non-hospitalized subjects with the SARS-CoV-2 infection, according to sex.
Patients and staff from the University Hospital in Krakow anonymously and retrospectively completed neuropsychological questionnaire that included eight symptoms of chronic fatigue syndrome. The presence of these symptoms was assessed before COVID-19 and 0-4, 4-12, and >12 weeks postinfection. The inclusion criteria were as follows: age 18 or more years, >12 weeks since the onset of the SARS-CoV-2 infection, and diagnosis confirmed by the RT-PCR from anasopharyngeal swab.
We included 303 patients (79.53% women, 47.52% medical personnel) assessed retrospectively after a median of 30 (interquartile range: 23-35) weeks since the onset of symptoms. A higher prevalence of at least one chronic fatigue symptom was found in females in all time intervals after the onset of COVID-19 compared to males (p < .036). Women, compared to men, more often experienced persistent fatigue, not caused by effort and persisting after rest (for <4 weeks, odds ratio [OR] = 2.31, 95% confidence interval [CI]: 1.13-4.73; for 4-12 weeks, OR = 1.95, 95% CI: 1.06-3.61), non-restorative sleep (for <4 weeks, OR = 2.17, 95% CI: 1.23-3.81; for >12 weeks, OR = 1.95, 95% CI: 1.03-3.71), and sore throat (for <4 weeks, OR = 1.97, 95% CI: 1.03-3.78; for 4-12 weeks, OR = 2.76, 95% CI: 1.05-7.27). Sex differences in headache, arthralgia, and prolonged postexercise fatigue were observed only during the first 4 weeks (OR = 2.59, 95% CI: 1.45-4.60, OR = 2.97, 95% CI: 1.02-8.64, and OR = 1.87, 95% CI: 1.01-3.51, respectively). There were no differences between women and men in myalgia and self-reported lymph node enlargement.
The course of post-COVID fatigue differs significantly between sexes in non-hospitalized individuals with COVID-19, with women more often suffering from persistent fatigue, not caused by effort and persisting after rest, non-restorative sleep, and sore throat.
关于非住院 COVID-19 患者的新冠后疲劳的性别差异,现有证据有限。因此,本研究旨在根据性别评估 SARS-CoV-2 感染后非住院患者慢性疲劳症状的进展情况。
克拉科夫大学医院的患者和工作人员匿名且回顾性地填写了神经心理学问卷,该问卷包括八项慢性疲劳综合征的症状。在 COVID-19 之前和感染后 0-4、4-12 和>12 周评估这些症状的存在。纳入标准为:年龄 18 岁或以上,距 SARS-CoV-2 感染开始>12 周,且通过鼻咽拭子的 RT-PCR 确诊。
我们纳入了 303 名患者(79.53%为女性,47.52%为医务人员),在症状出现后中位数 30(四分位距:23-35)周后进行回顾性评估。与男性相比,女性在 COVID-19 发病后的所有时间间隔内均出现至少一种慢性疲劳症状的发生率更高(p<.036)。与男性相比,女性更常出现持续性疲劳,这种疲劳不是由劳累引起的,且在休息后仍持续存在(<4 周,比值比 [OR] = 2.31,95%置信区间 [CI]:1.13-4.73;4-12 周,OR = 1.95,95% CI:1.06-3.61)、非恢复性睡眠(<4 周,OR = 2.17,95% CI:1.23-3.81;>12 周,OR = 1.95,95% CI:1.03-3.71)和咽痛(<4 周,OR = 1.97,95% CI:1.03-3.78;4-12 周,OR = 2.76,95% CI:1.05-7.27)。仅在最初的 4 周内观察到头痛、关节痛和运动后疲劳持续时间较长的性别差异(OR = 2.59,95% CI:1.45-4.60,OR = 2.97,95% CI:1.02-8.64,OR = 1.87,95% CI:1.01-3.51)。女性和男性在肌痛和自我报告的淋巴结肿大方面无差异。
在非住院 COVID-19 患者中,新冠后疲劳的进展在性别之间存在显著差异,女性更常出现持续性疲劳,这种疲劳不是由劳累引起的,且在休息后仍持续存在,还常出现非恢复性睡眠和咽痛。